Prior to joining the Institute for Systems Biology (ISB) in 2011, Dr. Price was an assistant professor at the University of Illinois at Urbana-Champaign, where he maintains adjunct appointments. Dr. Price has won numerous awards for his work, including an American Cancer Society Postdoctoral Fellowship, a Howard Temin Pathway to Independence Award from the National Institutes of Health (NIH), a National Science Foundation (NSF) CAREER award, and a young investigator award from the Roy J. Carver Charitable Trust. He has been named as one of the inaugural “Tomorrow’s PIs” by Genome Technology, and, most recently, as a Camille Dreyfus Teacher-Scholar. Dr. Price served on the National Academies-Institute of Medicine (IOM) committee to review omics-based tests to predict clinical outcome in clinical trials from 2010-2012. Dr. Price served on the scientific advisory board of TetraVitae Bioscience until it was acquired by Eastman Chemical in 2011. He now serves on the Scientific Advisory Boards of Trelys, Inc. and the Novo Nordisk Foundation Center for Biosustainability. He is also a member of the Board of Directors of the P4 Medicine Institute. He serves on the editorial boards of several scientific journals, including Science Translational Medicine, IEEE Life Science Letters, BMC Systems Biology, Industrial Biotechnology, and Biotechnology Journal, and was previously a Deputy Editor of PLOS Computational Biology.
Assoc. Director of the Institute for Systems Biology; Affiliate Faculty in Bioengineering, Computer Science & Engineering, and Molecular & Cellular Biology, Univ. of Washington